article thumbnail

Top Challenges for Pharma Marketing in 2025

Pharma Marketing Network

The world of pharma marketing is changing rapidly, and 2025 will be no exception. So, what will be the top challenges in 2025, and how can pharma marketers tackle them? Data Privacy and Compliance Challenges Data privacy is one of the most pressing concerns in 2025, especially with new regulations being enacted globally.

HIPAA 52
article thumbnail

The Power of Healthcare Branding: Strategies for Pharma Marketing Success in 2025

Pharma Marketing Network

As we approach 2025, the ability of pharmaceutical companies to effectively craft and communicate their brand identity will play a pivotal role in determining their market success. It provides a platform for consistent messaging, ensuring that the company’s values and commitments are clearly communicated and understood.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Amazon cuts ties with fertility benefits company Progyny

STAT

1, 2025, Amazon employees will no longer have access to Progyny’s services. ” The person asked not to be identified because Amazon is still communicating the change to its workers. Starting Jan. Instead, Amazon will use Maven as its fertility benefits vendor, the person said.

article thumbnail

op Pharma Marketing Trends Shaping the Future of Healthcare in 2025

Pharma Marketing Network

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharma companies and end-users.

article thumbnail

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments

Putting Patients First Blog

NHC 2025 Notice of Benefit and Payment Parameters (NBPP) Comments January 16, 2024 Allen Pinn, Coordinator, Policy The National Health Council (NHC) submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding the 2025 Notice of Benefit and Payment Parameters (NBPP) on January 8.

article thumbnail

NHC Comments on Draft CY 2025 Part D Redesign Program Instructions

Putting Patients First Blog

These guidelines should encompass rigorous scrutiny of the impact of the Manufacturer Discount Program on formulary decisions and UM practices, ensuring they support broad access to essential medications within the newly defined standard Part D benefit structure as outlined in the Draft CY 2025 Part D Redesign Program Instructions.

article thumbnail

NHC Comments on Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies

Putting Patients First Blog

However, we urge CMS to consider the following recommendations to ensure the 2025 policies further align with patient-centered care. The NHC recommends clear communication to beneficiaries about these changes and robust support systems to address any issues that may arise during the transition.